← Leaderboards
David Hyman
Sloan-Kettering Inst Can Research
$588,117
Attributed
$1,176,234
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $392.1K · FY2016–18$500K$375K$250K$125K$0
'16
'17
'18
Funding mix
By agency
NIH$1,176,234 · 1
By mechanism
R01$1,176,234 · 1
Top collaborators
- Barry Stephen Taylor3 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Scott W Lowe$63,222,126
- David B. Solit$21,393,031
- Barry Stephen Taylor$3,136,058
- Jian Zhang$3,523,685
- Sarat Chandarlapaty$10,852,142
Others in their field
Top investigators on “Correlative Study”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$446,953,021
- Lawrence Corey · Fred Hutchinson Cancer Center$337,263,601
- Leonard Freedman · Leidos Biomedical Research, Inc.$254,301,698
- Peter B. Gilbert · Fred Hutchinson Cancer Center$168,534,959
- Richard Webby · St. Jude Children'S Research Hospital$167,896,836
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$150,975,133
Research focus
Correlative StudyCoupled1-Phosphatidylinositol 3-KinaseAftercareAkt1 GeneAkt2 GeneAffectAkt InhibitionAllelesBaseBiological MarkersBiopsy SpecimenBloodCancer PatientAkt3 GeneCell Free DnaCellsClinical SequencingClinical TrialsClonalityCodon NucleotidesComplexComputer FrameworkCrispr/Cas Technology